Tuberculous pleural effusion: diagnosis & management

Nenhuma Miniatura disponível
Citações na Scopus
50
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS LTD
Citação
EXPERT REVIEW OF RESPIRATORY MEDICINE, v.13, n.8, p.747-759, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Tuberculosis (TB) is the world's leading cause of death from infectious disease. The World Health Organization (WHO) recognized 6.3 million new TB cases in 2017, 16% corresponding to extrapulmonary forms; pleural tuberculosis (PT) is the most common extrapulmonary form in adults. PT diagnosis is often challenging because the scarcity of bacilli in pleural fluid (PF), sometimes requiring invasive procedures to obtain pleural tissue for histological, microbiological or molecular examination. In regions of medium and high disease prevalence, adenosine deaminase (ADA), interferon gamma (IFN-gamma) and interleukin 27 (IL-27) dosages are useful to establish presumptive diagnosis in patients with compatible clinical/radiological picture who present with lymphocytic pleural effusion. PT treatment is similar to the pulmonary TB treatment regimen recommended by WHO. Area covered: In this update, we present a PT review, including epidemiology, pathogenesis, clinical features, diagnosis, and therapy. Expert opinion: There is no PF test alone accurate for PT diagnosis, despite the evolution in clinical laboratory. ADA, IFN-gamma and IL-27 are valuable laboratory biomarkers; however, IFN-gamma and IL-27 are quite expensive. Molecular tests present low sensitivity in PF, being useful for diagnostic confirmation. Multidrug therapy remains the PT treatment choice. Advancing research in immunotherapy may bring benefits to PT patients.
Palavras-chave
Biomarkers, management, mycobacterium tuberculosis, pleural fluid, pleural tuberculosis, treatment
Referências
  1. Aggarwal AN, 2016, INT J TUBERC LUNG D, V20, P1386, DOI 10.5588/ijtld.16.0298
  2. Aggarwal AN, 2015, J CLIN MICROBIOL, V53, P2451, DOI 10.1128/JCM.00823-15
  3. Amer S, 2016, INT J MYCOBACT, V5, P437, DOI 10.1016/j.ijmyco.2016.07.001
  4. Antonangelo L, 2012, J BRAS PNEUMOL, V38, P181, DOI 10.1590/S1806-37132012000200006
  5. BARNES PF, 1989, J IMMUNOL, V142, P1114
  6. Barthwal M S, 2016, Indian J Chest Dis Allied Sci, V58, P17
  7. BERGER HW, 1973, CHEST, V63, P88, DOI 10.1378/chest.63.1.88
  8. Bielsa S, 2018, ARCH BRONCONEUMOL, V2896, P30178
  9. BRISSONNOEL A, 1991, LANCET, V338, P364, DOI 10.1016/0140-6736(91)90492-8
  10. Cameron R, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002312.pub3
  11. Carnevale GG, 2018, CLINICS, V73, DOI 10.6061/clinics/2017/e410
  12. Viedma EC, 2006, RESP MED, V100, P2037, DOI 10.1016/j.rmed.2006.02.010
  13. CHAN CHS, 1991, RESPIRATION, V58, P171
  14. Choi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165428
  15. Chung CL, 2008, EUR RESPIR J, V31, P1261, DOI 10.1183/09031936.00122207
  16. Conde MB, 2003, AM J RESP CRIT CARE, V167, P723, DOI 10.1164/rccm.2111019
  17. Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814
  18. dePablo A, 1997, CHEST, V112, P1293, DOI 10.1378/chest.112.5.1293
  19. Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103
  20. Dinnes J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11030
  21. Elliott AM, 2004, J INFECT DIS, V190, P869, DOI 10.1086/422257
  22. Engel ME, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001876.pub2
  23. EPSTEIN DM, 1987, CHEST, V91, P106, DOI 10.1378/chest.91.1.106
  24. Ferreiro L, 2014, ARCH BRONCONEUMOL, V50, P435, DOI 10.1016/j.arbres.2013.07.006
  25. Ferrer J, 1997, EUR RESPIR J, V10, P942
  26. Frank W, 2014, THORACOSCOPY PULMONO, P121
  27. Gakis C, 1996, EUR RESPIR J, V9, P632, DOI 10.1183/09031936.96.09040632
  28. GALARZA I, 1995, THORAX, V50, P1305, DOI 10.1136/thx.50.12.1305
  29. Gopi A, 2007, CHEST, V131, P880, DOI 10.1378/chest.06-2063
  30. Goto M, 2003, ANN CLIN BIOCHEM, V40, P374, DOI 10.1258/000456303766477011
  31. Greco S, 2003, INT J TUBERC LUNG D, V7, P777
  32. Gui XW, 2014, INT J CLIN EXP MED, V7, P3126
  33. Hasaneen NA, 2003, CHEST, V124, P2105, DOI 10.1378/chest.124.6.2105
  34. HERNANDO HRV, 1987, CHEST, V91, P342, DOI 10.1378/chest.91.3.342
  35. Hiraki A, 2004, CHEST, V125, P987, DOI 10.1378/chest.125.3.987
  36. Hooper Clare, 2010, Thorax, V65 Suppl 2, pii4, DOI 10.1136/thx.2010.136978
  37. Hooper CE, 2009, CURR OPIN PULM MED, V15, P358, DOI 10.1097/MCP.0b013e32832bcc4e
  38. Jiang J, 2007, CHEST, V131, P1133, DOI 10.1378/chest.06-2273
  39. Keng LT, 2013, J INFECTION, V67, P294, DOI 10.1016/j.jinf.2013.05.009
  40. Kirsch CM, 1997, CHEST, V112, P702, DOI 10.1378/chest.112.3.702
  41. Koegelenberg CFN, 2011, RESPIROLOGY, V16, P738, DOI 10.1111/j.1440-1843.2011.01973.x
  42. Koegelenberg CFN, 2010, THORAX, V65, P857, DOI 10.1136/thx.2009.125146
  43. Kohli M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012768.pub2
  44. Lai YF, 2003, THORAX, V58, P149, DOI 10.1136/thorax.58.2.149
  45. Laniado-Laborin R, 2005, CHEST, V127, P417, DOI 10.1378/chest.127.2.417
  46. Lee BH, 2015, J KOREAN MED SCI, V30, P871, DOI 10.3346/jkms.2015.30.7.871
  47. LEE CH, 1988, CHEST, V94, P1256, DOI 10.1378/chest.94.6.1256
  48. Lee J, 2017, INFECTION, V45, P59, DOI 10.1007/s15010-016-0928-5
  49. LEVINE H, 1970, ARCH INTERN MED, V126, P269, DOI 10.1001/archinte.126.2.269
  50. Li M, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009205
  51. Li ZZ, 2015, GENET MOL RES, V14, P11672, DOI 10.4238/2015.September.28.19
  52. Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007
  53. Light RW, 2010, RESPIROLOGY, V15, P451, DOI 10.1111/j.1440-1843.2010.01723.x
  54. Liu Q, 2018, RESPIRATION, V95, P469, DOI 10.1159/000486963
  55. Loddenkemper R, 2013, PRINCIPLES PRACTICE, P605
  56. Luo Y, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00010
  57. Luzze H, 2001, INT J TUBERC LUNG D, V5, P746
  58. MAARTENS G, 1991, THORAX, V46, P96, DOI 10.1136/thx.46.2.96
  59. Mehta PK, 2012, FEMS IMMUNOL MED MIC, V66, P20, DOI 10.1111/j.1574-695X.2012.00987.x
  60. Meldau R, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-58
  61. Mollo B, 2017, ANN BIOL CLIN-PARIS, V75, P19, DOI 10.1684/abc.2016.1201
  62. Moon JW, 2005, CLIN INFECT DIS, V41, P660, DOI 10.1086/432474
  63. Morisson Patrizio, 2008, J. bras. pneumol., V34, P217, DOI 10.1590/S1806-37132008000400006
  64. Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6
  65. Palma RM, 2019, ARCH BRONCONEUMOL, V55, P23, DOI 10.1016/j.arbres.2018.05.007
  66. Pang CS, 2015, PEERJ, V3, DOI 10.7717/peerj.951
  67. Pang Y, 2019, EMERG INFECT DIS, V25, P457, DOI 10.3201/eid2503.180572
  68. PATIALA JORMA, 1954, ACTA TUBERC SCAND SUPPL, V36, P1
  69. Penz E, 2015, INT J TUBERC LUNG D, V19, P278, DOI 10.5588/ijtld.14.0262
  70. Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559
  71. PIRAS MA, 1978, BRIT MED J, V2, P1751, DOI 10.1136/bmj.2.6154.1751-a
  72. Porcel JM, 2009, LUNG, V187, P263, DOI 10.1007/s00408-009-9165-3
  73. Prasad B N B M, 2015, Indian J Tuberc, V62, P143, DOI 10.1016/j.ijtb.2015.09.010
  74. Ramos-Espinosa O, 2018, EXPERT REV RESP MED, V12, P427, DOI 10.1080/17476348.2018.1457439
  75. ROPER WH, 1955, AM REV TUBERC PULM, V71, P616
  76. Ruan SY, 2012, THORAX, V67, P822, DOI 10.1136/thoraxjnl-2011-201363
  77. Ryan H, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001876.pub3
  78. Sahn SA, 2013, INT J TUBERC LUNG D, V17, P787, DOI 10.5588/ijtld.12.0892
  79. Sahn S A, 1999, Semin Respir Infect, V14, P82
  80. SAKS AM, 1992, CLIN RADIOL, V46, P387, DOI 10.1016/S0009-9260(05)80684-1
  81. Sehgal IS, 2016, J CLIN MICROBIOL, V54, P1133, DOI 10.1128/JCM.03205-15
  82. Seiscento M, 2009, J BRAS PNEUMOL, V35, P548, DOI 10.1590/S1806-37132009000600008
  83. Sharma S K, 1996, Indian J Chest Dis Allied Sci, V38, P69
  84. Sharma SK, 2002, J CLIN IMMUNOL, V22, P345, DOI 10.1023/A:1020604331886
  85. SHIMOKATA K, 1991, CHEST, V99, P1103, DOI 10.1378/chest.99.5.1103
  86. Sivakumar P, 2017, INT J TUBERC LUNG D, V21, P697, DOI 10.5588/ijtld.16.0803
  87. Skouras VS, 2016, CURR OPIN PULM MED, V22, P367, DOI 10.1097/MCP.0000000000000277
  88. Solovic I, 2013, EUROSURVEILLANCE, V18, P12
  89. STEAD WW, 1955, AM REV TUBERC PULM, V71, P473
  90. Steingart KR, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub3
  91. Thillai M, 2014, EXPERT REV RESP MED, V8, P67, DOI 10.1586/17476348.2014.852471
  92. Udwadia ZF, 2010, CURR OPIN PULM MED, V16, P399, DOI 10.1097/MCP.0b013e328339cf6e
  93. VALDES L, 1993, CHEST, V103, P458, DOI 10.1378/chest.103.2.458
  94. Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017
  95. Valdes L, 2012, EUR J INTERN MED, V23, P727, DOI 10.1016/j.ejim.2012.06.014
  96. Garrido VV, 2014, ARCH BRONCONEUMOL, V50, P235, DOI 10.1016/j.arbres.2014.01.016
  97. von Groote-Bidlingmaier F, 2013, THORAX, V68, P290, DOI 10.1136/thoraxjnl-2012-202338
  98. Wang JL, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0526-z
  99. Wang W, 2018, THORAX, V73, P240, DOI 10.1136/thoraxjnl-2016-209718
  100. Wang XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112213
  101. WHO, 2019, CONS GUID DRUG RES T
  102. Wong CF, 2003, RESP MED, V97, P1289, DOI 10.1016/j.rmed.2003.07.003
  103. Wong PC, 2005, RESPIROLOGY, V10, P144, DOI 10.1111/j.1440-1843.2005.00689.x
  104. Word Health Organization, 2019, GUID POL BRIEFS HIV
  105. World Health Organization, 2018, GLOB TUB REP 2018
  106. World Health Organization, 2017, GUID TREATM DRUG SUS
  107. Wu YB, 2013, CHINESE MED J-PEKING, V126, P3215, DOI 10.3760/cma.j.issn.0366-6999.20130020
  108. Wyser C, 1996, CHEST, V110, P333, DOI 10.1378/chest.110.2.333
  109. Xie SS, 2017, ONCOTARGET, V8, P83315, DOI 10.18632/oncotarget.18160
  110. Xirouchaki N, 2002, CHEST, V121, P815, DOI 10.1378/chest.121.3.815
  111. Zemlin AE, 2009, INT J TUBERC LUNG D, V13, P214
  112. Zeng N, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0530-3
  113. Zhai K, 2016, J THORAC DIS, V8, pE486, DOI 10.21037/jtd.2016.05.87
  114. Zhou QO, 2011, RESPIROLOGY, V16, P473, DOI 10.1111/j.1440-1843.2011.01941.x